CVS Inventory Surges On Q3 Earnings, Revenue Outlook, Opioid Settlement

4

[ad_1]

CVS Well being Corp.  (CVS)  posted better-than-expected third quarter earnings Wednesday, and lifted its full-year revenue forecast, offsetting the affect of a $5 billion settlement to settle lawsuits linked to the U.S. opioid disaster.  

CVS mentioned adjusted earnings for the three months ending in September had been pegged at $2.09 per share, up 6.1% from the identical interval final 12 months and 10 cents forward of the Avenue consensus forecast. Group revenues, CVS mentioned, rose 10% from final 12 months to $81.2 billion, once more topping analysts’ estimates of a $76.5 billion tally.



[ad_2]
Source link